At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases).Learn More
Eisai's commitment to innovative solutions in disease prevention, treatment, and care for the health and well-being of people worldwide is embodied in our human health care (hhc) mission. Our goal is to give our first thoughts to patients and their families and helping to increase the benefits health care provides.Learn More
Magnolia Paws for Compassion is a special program, created by Eisai Inc., in partnership with the Epilepsy Foundation and 4 Paws for Ability, which seeks to increase access to animal assistance and raise awareness of the many benefits that service and therapy dogs can provide to those coping with an illness, such as epilepsy or a seizure disorder. Magnolia Paws for Compassion embodies Eisai's hhc mission by involving our employees in fundraising to support animal assistance and encouraging them to have their own pets trained as therapy dogs. Once trained, they spend time with patients, helping to alleviate some of the emotional and physical stresses associated with illness, while also gaining an understanding of the patient's journey to help inform and motivate their work.Learn More
Magnolia Paws for Compassion® is sponsored by Eisai Inc. Magnolia Paws for Compassion® is a registered trademark of Eisai Inc.